11 Patents
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- US122470582025Nucleic Acids Encoding Modified FGF-21 Polypeptides, Vectors and Cells Containing, and Use Thereof
BRISTOL-MYERS SQUIBB COMPANY
0 cites - 0 cites
- US120972412024Methods of Treating Kidney Failure, And/or Improving or Stablizing Renal Function Using Modified Relaxin Polypeptides
BRISTOL-MYERS SQUIBB COMPANY
0 cites - US120972422024Treatment of Fibrosis, Cardiovascular Disease and Heart Failure with Modified Relaxin Polypeptides
BRISTOL-MYERS SQUIBB COMPANY
0 cites - 0 cites
- US118589792024Fibronectin Based Scaffold Domain Proteins That Bind PCSK9
Bristol-meyers Squibb Company
0 cites - US118133152023Fibronectin Based Scaffold Domain Proteins That Bind to Myostatin
Bristol-myers Squibb Company
0 cites